Americord Expands Manhattan Offices

NEW YORK–(BUSINESS WIRE)– Americord, the fastest growing cord blood bank in the country, and a
leader in the advancement of umbilical cord blood, cord tissue, and
placenta tissue banking, is expanding its New York offices.

With the company’s focus on innovation fueling continued growth in the
cord blood banking space, Americord has outgrown its former
headquarters. To keep pace with its commitment to quality, technology,
and customer service, the company is strategically recruiting additional
cord blood specialists, client service representatives, and medical
researchers.

”As we transition to a larger organization, our commitment to customers,
employees, and values remain at the core of everything we do,” says
Martin Smithmyer, CEO. “As we scale the team, all are looking forward to
delivering on our promise of excellence in cord blood, cord tissue, and
placenta tissue banking.”

Americord’s new headquarters are located in the Financial District at
139 Fulton Street, Suite 707, New York, NY 10038.

About Americord Registry (“Americord”)

Americord Registry is a leader in the advancement of umbilical cord
blood, cord tissue and placenta tissue banking. Americord collects,
processes, and stores newborn stem cells from umbilical cord blood for
future medical or therapeutic use, including the treatment of more than
80 blood diseases such as sickle cell anemia and leukemia. Founded in
2008, Americord is registered with the FDA and operates in all 50
states. The company’s laboratory is CLIA Certified, accredited by the
AABB and complies with all federal and state guidelines and applicable
licenses. Americord is headquartered in New York, NY. For more
information, visit www.americordblood.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20160907006765/en/